Home > HSE data management and performance profile reports 2025.

Health Service Executive. (2026) HSE data management and performance profile reports 2025. Dublin: Health Service Executive.

[img]
Preview
PDF (HSE management data report December 2025)
2MB
[img]
Preview
PDF (HSE performance profile report December 2025)
3MB
[img]
Preview
PDF (HSE data management report - October 2025)
2MB
[img]
Preview
PDF (HSE data management report - September 2025)
2MB
[img]
Preview
PDF (HSE performance profile report - September 2025)
12MB
[img]
Preview
PDF (HSE data management report - August 2025)
3MB
[img]
Preview
PDF (HSE performance profile report - August 2025)
11MB
[img]
Preview
PDF (HSE management data report July 2025)
3MB
[img]
Preview
PDF (HSE performance profile report June / July 2025)
8MB
[img]
Preview
PDF (HSE performance profile report May 2025)
9MB

External website: https://www.hse.ie/eng/services/publications/perfo...


NPR management data report December 2025 (p.126)

Needle Exchange (p.124)

  • S146 No of unique individuals attending the Pharmacy Needle Exchange Programme: national 1,421 - September 2025.

Homeless Services (p.124) 

  • SI53 % of new individual homeless service users admitted to Supported Temporary Accommodations (STA), Private Emergency Accommodations (PEA), and/or Temporary Emergency Accommodations (TEA) during the quarter whose health needs have been assessed and are being supported to manage e.g. their physical / general health, mental health and / or addiction issues as part of their care / support plan: national 82.3% - December 2025. 

Substance Use (p.125) 

  • S122 % of substance users (over 18 years) for whom treatment has commenced within one calendar month following assessment: national 94.5% - September 2025
  • S125 % of substance users (under 18 years) for whom treatment has commenced within one week following assessment: national 97.9% - September 2025

Opioid Agonist Treatment (p.126)

  • SI1 Total no. of clients in receipt of opioid agonist treatment (outside prisons): national 9,886 - November 2025 [regional data also given]
  • SI64 Mean time in Clinics from referral to assessment for opioid agonist treatment: national 2.4 days - November 2025
  • SI65 Mean time in Clinics from opioid agonist treatment assessment to treatment commenced: national 4.2 days - November 2025

Problem Alcohol Use (p.126)

  • S136 % of problem alcohol users (over 18 years) for whom treatment has commenced within one calendar month following assessment: national 96.5% - September 2025
  • S139 % of problem alcohol users (under 18 years) for whom treatment has commenced within one week following assessment: national 100% - September 2025

Tobacco (p.9) 

  • HWB27 No. of smokers who received face to face or telephone intensive cessation support from a HSE trained and accredited stop smoking advisor: National activity year to date 21,125
  • HWB27B No. of smokers who received face to face or telephone intensive cessation support from a HSE trained and accredited stop smoking advisor (Community): National activity year to date 12,142 
  • HWB27C No. of smokers who received face to face or telephone intensive cessation support from a HSE trained and accredited stop smoking advisor (Hospitals): National activity year to date 3,978 
  • HWB27D No. of smokers who received face to face or telephone intensive cessation support from a HSE trained and accredited stop smoking advisor (Quitline): National activity year to date 5,005 
  • HWB101 No. of smokers who are receiving online cessation support services: National activity year to date 9,276 
  • HWB26 % of smokers on cessation programmes who were quit at four weeks: National activity year to date 57.7%
  • WB110 % of smokers engaging with HSE Stop Smoking Services and using recommended Stop Smoking Medicines: National activity year to date 7.9% 

Environmental Health (p.15) 

  • HWB29 No. of initial tobacco sales and/or nicotine inhaling product sales to minors test purchase inspections carried out: Activity year to date - 384
  • HWB93 No. of inspections of e-cigarette and refill container manufacturers, importers, distributors and retailers under the E.U. (Manufacture, Presentation and Sale of Tobacco and Related Products) Regulations 201: National activity year to date 40

HSE performance report December 2025 - social inclusion (substance use) page 28

Management data report November 2025

________________________________________

NPR management data report October 2025 (p.115)

Opioid Agonist Treatment
SI1 Total no. of clients in receipt of opioid agonist treatment (outside prisons): national 9,932 - September 2025 [regional data also given]
SI64 Mean time in Clinics from referral to assessment for opioid agonist treatment: national 3.5 days - September 2025
SI65 Mean time in Clinics from opioid agonist treatment assessment to treatment commenced: national 6.6 days - September 2025

______________________________________________

Management data report September 2025 (p.121) 

Opioid Agonist Treatment 
SI1 Total no. of clients in receipt of opioid agonist treatment (outside prisons): national 10,058 - August 2025 [regional data also given]
SI64 Mean time in Clinics from referral to assessment for opioid agonist treatment: national 6.6 days - August 2025
SI65 Mean time in Clinics from opioid agonist treatment assessment to treatment commenced: national 5.9 days - August 2025

Performance profile September 2025

P.28 Social inclusion

S125 - Substance users (under 18 years) for whom treatment has commenced within one week following assessment
Key messages, Early treatment helps prevent long-term addiction and related health and social problems. This represents 145 people year to date.

_____________________________________________________

Management data report August 2025 (p.103) 

Opioid Agonist Treatment 
SI1 Total no. of clients in receipt of opioid agonist treatment (outside prisons): national 10,057 - July 2025 [regional data also given]
SI64 Mean time in Clinics from referral to assessment for opioid agonist treatment: national 2.4 days - July 2025
SI65 Mean time in Clinics from opioid agonist treatment assessment to treatment commenced: national 3.6 days - July 2025

Performance profile August 2025

P.28 Social inclusion

S125 - Substance users (under 18 years) for whom treatment has commenced within one week following assessment
Key messages, Early treatment helps prevent long-term addiction and related health and social problems. This represents 75 people year to date.

_____________________________________________________

Management data report June 2025 (p.120) and July 2025 (p.110)

Opioid Agonist Treatment
SI1 Total no. of clients in receipt of opioid agonist treatment (outside prisons) 
SI64 Mean time in Clinics from referral to assessment for opioid agonist treatment
SI65 Mean time in Clinics from opioid agonist treatment assessment to treatment commenced

Performance profile June and July 2025

P.29 Social inclusion

S125 - Substance users (under 18 years) for whom treatment has commenced within one week following assessment
Key messages, Early treatment helps prevent long-term addiction and related health and social problems. This represents 75 people year to date.

___________________________________________________

Other reports:

For further information on HSE key performance indicators, see their annual report

Item Type
Report
Publication Type
Irish-related, Report
Drug Type
Alcohol, All substances, Opioid, Tobacco / Nicotine
Intervention Type
Treatment method, Harm reduction, Policy
Date
March 2026
Publisher
Health Service Executive
Corporate Creators
Health Service Executive
Place of Publication
Dublin
EndNote
Related (external) link
Subjects
B Substances > Substances in general
B Substances > Alcohol
B Substances > Tobacco (cigarette smoking)
B Substances > Tobacco (cigarette smoking) > Nicotine product (e-cigarette / vaping / heated)
B Substances > Opioids (opiates)
G Health and disease > Substance use disorder (addiction) > Alcohol use disorder
HJ Treatment or recovery method > Substance disorder treatment method > Substance replacement method (substitution) > Opioid agonist treatment (methadone maintenance / buprenorphine)
HJ Treatment or recovery method > Substance disorder treatment method > Cessation of tobacco / nicotine use
J Health care, prevention, harm reduction and treatment > Health related issues > Health information and education > Communicable / infectious disease control > Needle syringe distribution and exchange
J Health care, prevention, harm reduction and treatment > Treatment and maintenance > Treatment factors
J Health care, prevention, harm reduction and treatment > Health care delivery
J Health care, prevention, harm reduction and treatment > Health care programme, service or facility
J Health care, prevention, harm reduction and treatment > Health care administration > Health care quality control
L Social psychology and related concepts > Social inclusion and exclusion
L Social psychology and related concepts > Waiting for a product or service
MA-ML Social science, culture and community > Social condition > Homelessness > Homeless services
T Demographic characteristics > Adolescent / youth (teenager / young person)
T Demographic characteristics > Adult
T Demographic characteristics > Homeless / unhoused person
VA Geographic area > Europe > Ireland
VA Geographic area > Europe > Ireland > County / regional data

Repository Staff Only: item control page